Medicines and Healthcare products Regulatory Agency

New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS.

Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime.

Avacopan Vifor is used in the treatment of some rare autoimmune diseases affecting small blood vessels. 

While most patients implanted with these hip replacements have well-functioning hips and are unlikely to develop serious problems, a small number may develop issues.

MHRA advises parents and carers against using rectal catheters sold for personal use (known as gas and colic relievers) in babies.

MHRA publishes position paper clarifying the UK licencing route for microbiome-based medicines, supporting developers to bring these innovative therapies to patients.